Tumor suppressor p53 inhibits systemic autoimmune diseases by inducing regulatory T cells. 2013

Hirotoshi Kawashima, and Hiroaki Takatori, and Kotaro Suzuki, and Arifumi Iwata, and Masaya Yokota, and Akira Suto, and Tohru Minamino, and Koichi Hirose, and Hiroshi Nakajima
Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.

The tumor suppressor p53 plays a central role in tumor suppression by inducing apoptosis, cell cycle arrest, senescence, and DNA repair. In addition to the antitumor functions of p53, accumulating evidence using systemic p53-deficient mice suggests that p53 suppresses autoimmunity. However, it remains unknown how p53 suppresses autoimmunity. In this study, we generated T cell-specific p53-deficient mice (CD4-Cre p53(fl/fl) mice, or p53 conditional knockout [cKO] mice) and found that aged p53-cKO mice spontaneously developed inflammatory lesions in various organs, including lung, liver, stomach, thyroid gland, submandibular gland, and kidney. Additionally, anti-nuclear Abs and autoantibodies against gastric parietal cells were detected in p53-cKO mice but not in control p53(fl/fl) mice (p53 wild-type mice). Importantly, the number of Foxp3(+)CD4(+) regulatory T cells (Tregs) in the spleen and lung as well as in vitro differentiation of induced Tregs was significantly reduced in p53-cKO mice as compared with that in p53 wild-type mice. Regarding the mechanisms underlying p53-mediated Treg induction, p53 enhanced the transcription of Foxp3 by binding to the promoter and the conserved noncoding DNA sequence-2 of the Foxp3 gene. Taken together, these results suggest that p53 expressed in T cells functions as a suppressor for autoimmunity by inducing Treg differentiation.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Hirotoshi Kawashima, and Hiroaki Takatori, and Kotaro Suzuki, and Arifumi Iwata, and Masaya Yokota, and Akira Suto, and Tohru Minamino, and Koichi Hirose, and Hiroshi Nakajima
October 2011, Autoimmunity reviews,
Hirotoshi Kawashima, and Hiroaki Takatori, and Kotaro Suzuki, and Arifumi Iwata, and Masaya Yokota, and Akira Suto, and Tohru Minamino, and Koichi Hirose, and Hiroshi Nakajima
May 2005, Diabetes,
Hirotoshi Kawashima, and Hiroaki Takatori, and Kotaro Suzuki, and Arifumi Iwata, and Masaya Yokota, and Akira Suto, and Tohru Minamino, and Koichi Hirose, and Hiroshi Nakajima
February 2005, Cancer research,
Hirotoshi Kawashima, and Hiroaki Takatori, and Kotaro Suzuki, and Arifumi Iwata, and Masaya Yokota, and Akira Suto, and Tohru Minamino, and Koichi Hirose, and Hiroshi Nakajima
April 2009, Endocrinology,
Hirotoshi Kawashima, and Hiroaki Takatori, and Kotaro Suzuki, and Arifumi Iwata, and Masaya Yokota, and Akira Suto, and Tohru Minamino, and Koichi Hirose, and Hiroshi Nakajima
June 2019, Experimental dermatology,
Hirotoshi Kawashima, and Hiroaki Takatori, and Kotaro Suzuki, and Arifumi Iwata, and Masaya Yokota, and Akira Suto, and Tohru Minamino, and Koichi Hirose, and Hiroshi Nakajima
October 2008, Trends in endocrinology and metabolism: TEM,
Hirotoshi Kawashima, and Hiroaki Takatori, and Kotaro Suzuki, and Arifumi Iwata, and Masaya Yokota, and Akira Suto, and Tohru Minamino, and Koichi Hirose, and Hiroshi Nakajima
December 2010, Current opinion in immunology,
Hirotoshi Kawashima, and Hiroaki Takatori, and Kotaro Suzuki, and Arifumi Iwata, and Masaya Yokota, and Akira Suto, and Tohru Minamino, and Koichi Hirose, and Hiroshi Nakajima
January 2008, The Israel Medical Association journal : IMAJ,
Hirotoshi Kawashima, and Hiroaki Takatori, and Kotaro Suzuki, and Arifumi Iwata, and Masaya Yokota, and Akira Suto, and Tohru Minamino, and Koichi Hirose, and Hiroshi Nakajima
August 2006, Springer seminars in immunopathology,
Hirotoshi Kawashima, and Hiroaki Takatori, and Kotaro Suzuki, and Arifumi Iwata, and Masaya Yokota, and Akira Suto, and Tohru Minamino, and Koichi Hirose, and Hiroshi Nakajima
February 2010, La Revue de medecine interne,
Copied contents to your clipboard!